Pharmaceutical combination for curing acute radiation dermatitis
A radiation dermatitis and composition technology, which is applied in the field of pharmaceutical compositions for the treatment of acute radiation dermatitis, can solve the problems of tumor treatment such as low expectations, achieve the effects of no toxic side effects and adverse reactions, quick results, and promote skin growth
Inactive Publication Date: 2008-09-03
刘焕臣
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, none of them clearly reported on the continuation of radiation therapy while treating acute radiation dermatitis.
For tumor patients, if the problem of continuing radiation therapy cannot be solved while treating acute radiation dermatitis, the expectation for tumor treatment is very slim
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0016] Grind 10 mg of oryzanol, dissolve it with 10 mg of polymyocytes, mix well, gradually add 20,000 U of vitamin A dissolved in ethanol, and then add distilled water to prepare a 50 ml solution.
Embodiment 2
[0018] Grind 50mg of oryzanol, mix with 15mg of polymyocytes, 100mg of vitamin B 1 The injections are dissolved together, after mixing evenly, gradually add 30,000 U of vitamin A dissolved in ethanol, and then add distilled water to prepare a 50ml solution.
Embodiment 3
[0020] According to the method of the above example, 20 mg of polymyocytes, 50,000 U of vitamin A, 100 mg of oryzanol, and vitamin B 6 Add 50mg of distilled water to prepare 50ml of solution.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention discloses a pharmaceutical composition for treating acute radiodermatitis, and comprises polyriboinosinic -polyribocytidylic acid 10-20mg, vitamin A 20,000-50,000IU and oryzanol 10-100mg. The above ingredients can be prepared into 50ml solution with a proper amount of distilled water and ethanol. Through clinic experiments, it is proved that the inventive composition can be used for treating acute radiodermatitis while continuing conducing radiotherapy, so as to ensure the anticipated tumor treatment effect, and also has therapeutic effect on chronic radiodermatitis. The inventive pharmaceutical composition has only therapeutic action on diseased tissues and has no any damage to healthy tissues; has antiphlogistic, antiallergic, radioactive rays resisting, analgesic, antipruritic and skin growth promoting effects; and has the advantages of no sedatives, no analgesics, no hormones, quick action, high cure rate, no recurrence, and no toxic or side effects.
Description
technical field [0001] The invention relates to a medicine, especially a medicine composition for treating acute radiation dermatitis. Background technique [0002] Radiation dermatitis, also known as skin radiation damage or radiation burn, refers to various types of ionizing radiation, including microparticle waves or electronic waves, acting on the surface of the human body, causing any visible early or late lesions on the skin and its appendages, which can be divided into acute and There are two types of chronic radiation dermatitis. Acute radiation dermatitis refers to the acute skin injury caused by local exposure to one or multiple large doses of external radiation (X, γ, β rays) within a short period of time (several days). Early manifestations: slight skin pigmentation, erythema, itching, pain or edema. Late manifestations: exudation, blisters, erosions, ulcers or necrosis. According to the diagnostic criteria of GBZ106-2002 radiation skin disease, it can be divi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7088A61K38/18A61P17/00A61K31/07A61K31/4164A61K31/4415A61K31/51A61K31/575
Inventor 刘焕臣刘静坤池春
Owner 刘焕臣
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
